Literature DB >> 22312986

Avian influenza and Newcastle disease in three risk areas for H5N1 highly pathogenic avian influenza in Mali, 2007-2008.

S Molia1, K Samaké, A Diarra, M S Sidibé, L Doumbia, S Camara, S Kanté, B Kamissoko, A Diakité, P Gil, S Hammoumi, R Servan de Almeida, E Albina, V Grosboisa.   

Abstract

Our survey aimed to investigate avian influenza (AI) and Newcastle disease (ND) prevalence and risk factors in three areas of Mali at risk for occurrence of H5N1 highly pathogenic avian influenza. Blood samples and cloacal and oropharyngeal swabs were collected from 1470 birds between February 2007 and May 2008 and were tested by commercial enzyme-linked immunosorbent assay to detect antibodies and real-time reverse-transcription (rRT)-PCR to detect virus. Risk factors associated with seropositivity or positive rRT-PCR were identified by random effect logistic regression. AI seroprevalence was significantly lower in birds from commercial farms (0%) than in village backyard birds (3.1%). For backyard birds, no individual risk factors (species, age, sex) were identified, but birds in the Mopti area in the Sahelian zone, where millions of wild birds migrate, were more seropositive than in the Sikasso area in the Sudano-Guinean zone (odds ratio [OR] = 2.0, P = 0.051). Among backyard birds nonvaccinated against ND, ND seroprevalence was 58.4%, and the odds of seropositivity was 2.0 higher in chickens than in ducks, 1.7 higher in females than in males, 3.1 higher in adults than in young birds, and 3.0 higher in poultry from the Sikasso area than from the Mopti area (P < 0.01 in all cases). Prevalence established by rRT-PCR was low for both AI virus (1.1%) and ND virus (2.6%) and was associated with no risk factors for AI but was higher in chickens than in ducks (OR = 5.3, P = 0.05) and in the Sikasso area than in the Mopti area (OR = 3.4, P = 0.027) for ND. For AI and ND, prevalence assessed by serology or rRT-PCR varied over time, although seasonal and interannual variation could not be clearly distinguished. The intracluster correlation coefficient for serologic data was low for AI (0.014) and higher for ND (0.222). These results are useful to optimize surveillance and control strategy for notifiable avian diseases in African countries with similar agroecological and resource-limited contexts.

Entities:  

Mesh:

Year:  2011        PMID: 22312986     DOI: 10.1637/9775-050911-Reg.1

Source DB:  PubMed          Journal:  Avian Dis        ISSN: 0005-2086            Impact factor:   1.577


  5 in total

Review 1.  Epidemiology of Newcastle disease in poultry in Africa: systematic review and meta-analysis.

Authors:  Elifuraha Barnabas Mngumi; Fulgence Ntangere Mpenda; Joram Buza
Journal:  Trop Anim Health Prod       Date:  2022-06-15       Impact factor: 1.559

2.  Experimental co-infections of domestic ducks with a virulent Newcastle disease virus and low or highly pathogenic avian influenza viruses.

Authors:  Mary J Pantin-Jackwood; Mar Costa-Hurtado; Patti J Miller; Claudio L Afonso; Erica Spackman; Darrell R Kapczynski; Eric Shepherd; Diane Smith; David E Swayne
Journal:  Vet Microbiol       Date:  2015-02-16       Impact factor: 3.293

3.  Avian Influenza Viruses Detected in Birds in Sub-Saharan Africa: A Systematic Review.

Authors:  Annie Kalonda; Ngonda Saasa; Panji Nkhoma; Masahiro Kajihara; Hirofumi Sawa; Ayato Takada; Edgar Simulundu
Journal:  Viruses       Date:  2020-09-07       Impact factor: 5.048

4.  Risk factors and characteristics of low pathogenic avian influenza virus isolated from commercial poultry in Tunisia.

Authors:  Wafa Tombari; Mathilde Paul; Jihene Bettaieb; Imen Larbi; Jihene Nsiri; Imen Elbehi; Latifa Gribaa; Abdeljelil Ghram
Journal:  PLoS One       Date:  2013-01-11       Impact factor: 3.240

5.  Empirical analysis suggests continuous and homogeneous circulation of Newcastle disease virus in a wide range of wild bird species in Africa.

Authors:  J Cappelle; A Caron; R Servan De Almeida; P Gil; M Pedrono; J Mundava; B Fofana; G Balança; M Dakouo; A B Ould El Mamy; C Abolnik; O F Maminiaina; G S Cumming; M-N De Visscher; E Albina; V Chevalier; N Gaidet
Journal:  Epidemiol Infect       Date:  2014-08-04       Impact factor: 4.434

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.